Apr 18 |
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
|
Apr 2 |
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
|
Mar 26 |
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
|
Mar 8 |
Q4 2023 Sight Sciences Inc Earnings Call
|
Mar 8 |
Sight Sciences, Inc. (SGHT) Q4 2023 Earnings Call Transcript
|
Mar 8 |
Sight Sciences Inc (SGHT) Navigates Challenges to Maintain Revenue Growth and Reduce Expenses
|
Mar 7 |
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates
|
Mar 7 |
Sight Sciences GAAP EPS of -$0.22 beats by $0.12, revenue of $18.8M misses by $0.6M
|
Mar 7 |
Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
|
Mar 7 |
Earnings Scheduled For March 7, 2024
|